Diuretic Tuner Clinical Decision Support
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT04759274
- Status
- Recruiting
Conditions
- Chronic Kidney Diseases
- Edema
- Hypervolemia
- Nephrotic Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Diuretic Tuner — DEVICEMobile device application for diuretic dose titration
Study Details
This purpose of this study is to determine the effectiveness of a mobile phone application in helping to control body swelling in patients with kidney problems. The application will help in the day to day adjustments in diuretic medication dosing. Participants in this study will have an application loaded on to their mobile phone by the study team and be taught how to use it over a 2 hour visit. Participants will need to check their blood pressure and weight daily and enter this information into the mobile phone application every day. Participants will need to follow daily instructions in their medication dosing provided by the application. There will be periodic blood testing. This will happen at 2 weeks, 90 days, and up to 4 other times if necessary. At the end of the study there is a 2 hour study visit during which participants will answer a survey. The total length of the study is 90 days.
Key Dates
- Start date
- Nov 20, 2023
- Status verified
- Sep 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Diuretic Tuner usersThe Diuretic Tuner is a mobile device application that integrates a patient's estimated dry weight and starting diuretic dose (both defined by a healthcare provider) with daily weights and blood pressures to provide individualized guidance to the patient in day-to-day adjustments to his or her diuretic regimen. In addition, the application generates a diary of daily weights, blood pressures, fluid intake, and medication compliance.
Primary Outcome Measure
Mean time to the attainment of dry weight [ Time Frame: 90 days ]
Central Contacts
- Kamalanathan K Sambandam, M.D.214-645-6190
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern | Dallas | Texas | 75390 |
Find similar trials in Dallas, TX
Related Studies
- Pioglitazone to Reduce Sympathetic Overactivity in CKD PatientsPHASE4 · Recruiting · The University of Texas at Arlington · Arlington, Texas
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Kidney Precision Medicine ProjectRecruiting · Icahn School of Medicine at Mount Sinai · Tucson, Arizona
- Combination of Novel Therapies for CKD Comorbid DepressionPHASE2 · Recruiting · Stony Brook University · Stony Brook, New York